logo

For the Inventor, By the Inventor

Brookline, MA, United States of America

Harvey F Lodish

This inventor holds 34 USPTO granted patents and 8 published patent applications and 3 EPO patents, primarily in Hematopoietic Stem Cells. Top assignees: Whitehead Institute for Biomedical Research, Case Western Reserve University, The Government of the United States of America. Active years: 1994-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harvey F Lodish. Retrieved from https://idiyas.com/inventor/harvey-f-lodish

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 

% Patents Active = 79.4

 

Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 244(Granted Patents)


Location History:

  • Cambridge, MA (US) (2023)
  • Brookline, MA (US) (1994 - 2024)

Company Filing History:

goldMedal27 out of 318 
 
Whitehead Institute for Biomedical Research
 patents
silverMedal2 out of 1,368 
 
Case Western Reserve University
 patents
bronzeMedal2 out of 12 
 
The Government of the United States of America
 patents
4. 1 out of 1 
 
Carmine Therapeutics Pte. Ltd.
 patent
5. 1 out of 1 
 
Health Research Inc. Rosewell Park Division
 patent
6. 1 out of 8 
 
Health Research Inc., Roswell Park Division
 patents
7. 1 out of 855 
 
Millennium Pharmaceuticals Limited
 patents
8. 1 out of 62 
 
Serono Genetics Institute S.a.
 patents
9. 1 out of 2,173 
 
University of Washington
 patents
10. 5 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Protein Expression
Red Blood Cells
Hematopoietic Stem Cells
Sortase Recognition Motifs
Micro RNAs
Erythropoietin
Fatty Acid Transport Proteins
TGF-Beta Receptors
Transgenic Mammals
Erythroid Progenitors
Muscle Mass
Cell Expansion
34 patents (USPTO):Explore Patents
1. 12281314 - Methods and compositions for increasing protein expression and/or treating a haploinsufficiency disorder (2025-04-21),
2. 11992505 - In vitro production of red blood cells with proteins comprising sortase recognition motifs (2024-05-28),
3. 11970718 - Nucleic acid loaded extracellular vesicles (2024-04-30),
4. 11617802 - Methods and compositions for treating a premature stop codon-mediated disorder (2023-04-04),
5. 11371019 - Efficient generation of human red blood cells via enriching peripheral blood erythroid progenitors (2022-06-28),
6. 11266695 - In vitro production of red blood cells with sortaggable proteins (2022-03-08),
7. 10471099 - In vitro production of red blood cells with proteins comprising sortase recognition motifs (2019-11-12),
8. 8617885 - Cultured hematopoietic stem cells and method for expansion and analysis thereof (2013-12-31),
9. 8609832 - Methods and products for expression of micro RNAs (2013-12-17),
10. 8609411 - Ex vivo expansion of human hematopoietic stem cells (2013-12-17),
11. 8506955 - Methods for expansion and analysis of cultured hematopoietic stem cells (2013-08-13),
12. 8106180 - Methods and products for expression of micro RNAs (2012-01-31),
13. 7807464 - Methods for expansion and analysis of cultured hematopoietic stem cells (2010-10-05),
14. 7767453 - Cultured hematopoietic stem cells and method for expansion and analysis thereof (2010-08-03),
15. 7405193 - Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation (2008-07-29),

Title: The Innovative Journey of Harvey F. Lodish

Introduction: Harvey F. Lodish, a distinguished inventor based in Brookline, MA (US), has made significant contributions to the field of biotechnology and life sciences through his groundbreaking inventions and research endeavors.

Latest Patents: Harvey F. Lodish holds several patents in the areas of cell biology, biotechnology, and molecular genetics, showcasing his continuous commitment to innovation and scientific advancement.

Career Highlights: With a career spanning several decades, Harvey F. Lodish has established himself as a prominent figure in the scientific community. He is renowned for his pioneering work in the development of novel technologies and methodologies that have revolutionized the way we understand and manipulate biological systems.

Collaborations: Throughout his career, Harvey F. Lodish has collaborated with leading researchers, scientists, and institutions worldwide, fostering a culture of innovation and knowledge exchange. His collaborative efforts have led to the development of cutting-edge technologies and solutions that address some of the most pressing challenges in the field of biotechnology.

Conclusion: In conclusion, Harvey F. Lodish's unwavering dedication to innovation and his relentless pursuit of scientific excellence have solidified his reputation as a trailblazer in the field of biotechnology. His pioneering inventions and research have not only advanced our understanding of biological systems but have also paved the way for future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…